Biotech | August 09, 2021
AstraZeneca Pharma India PAT at Rs 10.24 crores
Board declares interim dividend of Rs 2 per equity share
Board declares interim dividend of Rs 2 per equity share
Board approves fundraise of Rs 1500 crore
Forex gains stood at Rs 20 crore for the quarter
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
EPS climbs to Rs 9.25 for the quarter
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
